抗血小板药在缺血性卒中防治中的作用  

The roles of Antiplatelet Agents in the Prevention and Treatment of Ischemic Stroke

作　　者：吴伟利[1] 于宗明[1] 荣军红 汤克仁[1] 

机构地区：[1]山东省淄博市中心医院神经科,255036

出　　处：《国外医学（脑血管疾病分册）》2004年第8期605-608,共4页Foreign Medical Sciences Cerebrovascular Diseases

摘　　要：抗血小板药在缺血性卒中防治中的作用已得到公认。阿司匹林可在缺血性卒中发病 2 4～ 4 8h内应用 ,并可用于缺血性卒中的二级预防。阿司匹林抵抗人群或对阿司匹林不能耐受者 ,可改用其他抗血小板药。文章主要探讨抗血小板药的临床应用、最佳剂量以及抗血小板药与其他干预手段的联合应用。The roles of antiplatelet agents in the prevention and treatment of ischemic stroke has been well accepted. Aspirin can be used within 24 to 48 hours after the onset of ischemic stroke. It can also be used in the secondary prevention of ischemic stroke. In populations who are aspirin-resistance or do not tolerate it, can use other antiplatelet agents. This article mainly discusses the clinical application and optimal dosage of the antiplatelet agent and its combination with other interventions.

关 键 词：抗血小板药 缺血性卒中 临床应用 阿司匹林抵抗 干预手段 二级预防 耐受 人群 

分 类 号：R743.3[医药卫生—神经病学与精神病学]